HIGHLIGHTS
- who: Mulder et_al BMC Cancer et al. from the Laboratory measurements* Every , weeks have published the article: STUDY PROTOCOL Early discontinuation of PD-1 blockade upon achieving complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial, in the Journal: (JOURNAL) of September/30,/2018
- what: The aim of the Safe Stop trial is to evaluate whether early discontinuation of first-line PD-1 blockade is safe in patients with advanced and metastatic melanoma who achieve a radiological response. For all included patients, data will be collected until the end . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.